Grünenthal Press Releases 2014

Grünenthal USA awarded 2014 Best Places to Work in New Jersey

Best Place to Work NJ 2014 - small to mid-size companies

We are pleased to announce that Grünenthal USA has been named one of the 2014 Best Places to Work in New Jersey. The survey identifies the top 100 companies in the state of New Jersey. The overall score is a combination of the results from an employee survey and an employer questionnaire detailing the types of benefits offered to employees. The top 100 ranking comprises 62 small/mid-sized companies (15-249 employees) and 38 large companies (250+ employees).

We are thrilled to have received this recognition and will continue to strive to make Grünenthal USA a great place to work!

About Grünenthal

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain treatment, its objective is to become the most patient-centric company and thus to be a leader in therapy innovation. Grünenthal is one of the last remaining five research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development. The research and development costs amounted to a preliminary of about 26 percent of revenues in 2012. Grünenthal′s research and development strategy concentrates on selected fields of therapy and state-of-the-art technologies. We are intensely focused on discovering new ways to treat pain better and more effectively, with fewer side-effects than current therapies. Altogether, the Grünenthal Group has affiliates in 26 countries worldwide. Grünenthal products are sold in more than 155 countries and today approx. 4,400 employees are working for the Grünenthal Group worldwide. In 2012, Grünenthal achieved preliminary revenues of € 973 mn.

More information:


Phillip von Gallwitz
Chief Executive Officer Grünenthal USA, Inc.
Grünenthal USA, Inc.
Bedminster, NJ 07921